Site-specific TREM2 cleavage fragments (N-terminal vs C-terminal ratios) serve as the primary readout for microglial priming state, with CHI3L1 (YKL-40) and neurogranin as confirmatory cascade markers that validate the temporal sequence of neuroinflammation. The mechanistic foundation centers on ADAM10/17-mediated TREM2 shedding as the proximal event that defines microglial transition from homeostatic surveillance to priming phase. This transition triggers downstream CHI3L1 expression and synapt
## Mechanistic Overview
Integrated Multi-Analyte CSF Panel Combining YKL-40, sTREM2, and Neurogranin starts from the claim that modulating CHI3L1/TREM2/NRGN within the disease context of biomarkers can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview Integrated Multi-Analyte CSF Panel Combining YKL-40, sTREM2, and Neurogranin starts from the claim that modulating CHI3L1/TREM2/NRGN within the disease context of biomarkers can redirect a disease-relevan
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
TREM2Neuroinflammationbiomarkers
Convergent signals
TREM2 recurs across 2 selected hypotheses with aligned directionality in neuroinflammation.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
7/11
dimensions won
CSF TREM2 Fragment Ratio Integrated with
10/11
dimensions won
Integrated Multi-Analyte CSF Panel Combi
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.65
0.65
Evidence
0.35
0.68
Novelty
0.00
0.65
Feasibility
0.00
0.82
Impact
0.00
0.78
Druggability
0.70
0.70
Safety
0.85
0.85
Competition
0.72
0.72
Data
0.80
0.80
Reproducible
0.65
0.65
KG Connect
0.53
0.50
Score Breakdown
Dimension
CSF TREM2 Fragment Ratio Integ
Integrated Multi-Analyte CSF P
Mechanistic
0.650
0.650
Evidence
0.350
0.680
Novelty
0.000
0.650
Feasibility
0.000
0.820
Impact
0.000
0.780
Druggability
0.700
0.700
Safety
0.850
0.850
Competition
0.720
0.720
Data
0.800
0.800
Reproducible
0.650
0.650
KG Connect
0.533
0.500
Evidence
CSF TREM2 Fragment Ratio Integrated with Neuroinflammatory C
CSF TREM2 Fragment Ratio Integrated with Neuroinfl
4 rounds · quality: 0.75
Persona-Theorist
# Biomarker Hypotheses for Detecting Microglial Priming States
---
## Hypothesis 1: TSPO PET Kinetic Modeling for Priming State Discrimination
**Title:** Distinguishing primed from dystrophic micro...
Persona-Skeptic
# Critical Evaluation of Microglial Priming Biomarker Hypotheses
## Hypothesis 1: TSPO PET Kinetic Modeling
### Weak Links
**Specificity Crisis.** TSPO is expressed on microglia, astrocytes, endoth...
Persona-Domain Expert
# Feasibility Assessment: Microglial Priming Biomarkers
## Executive Summary
The debate identified a fundamental translational gap: even validated microglial targets remain therapeutically inaccessi...
# Biomarker Hypotheses for Detecting Microglial Priming States
---
## Hypothesis 1: TSPO PET Kinetic Modeling for Priming State Discrimination
**Title:** Distinguishing primed from dystrophic micro...
Persona-Skeptic
# Critical Evaluation of Microglial Priming Biomarker Hypotheses
## Hypothesis 1: TSPO PET Kinetic Modeling
### Weak Links
**Specificity Crisis.** TSPO is expressed on microglia, astrocytes, endoth...
Persona-Domain Expert
# Feasibility Assessment: Microglial Priming Biomarkers
## Executive Summary
The debate identified a fundamental translational gap: even validated microglial targets remain therapeutically inaccessi...